(Q50584450)

16 March 2018

title

Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice (English)

1 reference

16 March 2018

1 reference

Mauricio Kunz

10

0 references

Adriane R Rosa

Adriane R Rosa

4

0 references

Márcia Kauer-Sant'Anna

8

Marcia Kauer-Sant'Anna

1 reference

16 March 2018

Clarissa Severino Gama

12

Clarissa S Gama

1 reference

16 March 2018

2

Joana Bücker

1 reference

16 March 2018

Mireia Vianna-Sulzbach

3

Mireia Vianna-Sulzbach

1 reference

16 March 2018

Iria Grande

5

Iria Grande

1 reference

16 March 2018

Ines Chendo

6

Ines Chendo

1 reference

16 March 2018

Raffael Massuda

13

Raffael Massuda

1 reference

16 March 2018

author name string

Pedro D Goi

1

1 reference

16 March 2018

Leonardo A Sodré

7

1 reference

16 March 2018

Leonardo Silveira

9

1 reference

16 March 2018

Keila M Ceresér

11

1 reference

16 March 2018

publication date

12 May 2015

1 reference

16 March 2018

Brazilian Journal of Psychiatry

published in

1 reference

16 March 2018

volume

37

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

121-125

1 reference

16 March 2018

Pharmacologic therapy for New York Heart Association class IV heart failure

cites work

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Staging and neuroprogression in bipolar disorder: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Progressive neurostructural changes in adolescent and adult patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Stage managing bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Setting the stage: from prodrome to treatment resistance in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Clinical implications of a staging model for bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

The clinical implications of cognitive impairment and allostatic load in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

The impact of staging bipolar disorder on treatment outcome of family psychoeducation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2014-1554

10.1590/1516-4446-2014-1554

21 January 2018

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018